Jefferies Starts Kite Pharma (KITE) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Credit Suisse Starts Kite Pharma (KITE) at Outperform
July 15, 2014 7:46 AM EDTCredit Suisse initiated coverage on Kite Pharma (NASDAQ: KITE) with an Outperform rating and a price target of $34.00.
Analyst Jason Kantor expressed enthusiasm for the CAR T and immuno-oncology space and the company's unique position in the field and fast-to-market strategy. Lead therapy,... More
Cowen Starts Kite Pharma (KITE) at Outperform
July 15, 2014 7:45 AM EDTCowen initiated coverage on Kite Pharma (NASDAQ: KITE) with an Outperform rating.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
... MoreStifel Nicolaus Starts Kite Pharma (KITE) at Buy
July 15, 2014 7:44 AM EDTStifel Nicolaus initiated coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
... More


